Estetrol/Drospirenone to Reduce the Average Size of Endometriomas

Clinical trial NCT05837624 · RECRUITING

Trial details

NCT number: NCT05837624
Sponsor: Andrew Zakhari
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ovarian Endometrioma Endometrioma

Start date: 2024-12-03
Primary completion: 2026-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.